Cargando…
Celecoxib decreases prostaglandin E(2 )concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer
BACKGROUND: Celecoxib inhibits PGE2 production in cancerous tissue. We previously reported that PGE2 levels in nipple aspirate fluid (NAF) and plasma were not decreased in women at increased breast cancer risk who received celecoxib 200 mg twice daily (bid). The endpoints of the current study were t...
Autores principales: | Sauter, Edward R, Qin, Wenyi, Schlatter, Lisa, Hewett, John E, Flynn, John T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1621075/ https://www.ncbi.nlm.nih.gov/pubmed/17049084 http://dx.doi.org/10.1186/1471-2407-6-248 |
Ejemplares similares
-
Celecoxib concentration predicts decrease in prostaglandin E(2 )concentrations in nipple aspirate fluid from high risk women
por: Sauter, Edward R, et al.
Publicado: (2008) -
Proteins and carbohydrates in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy
por: Qin, Wenyi, et al.
Publicado: (2012) -
uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer
por: Qin, Wenyi, et al.
Publicado: (2008) -
Carbohydrate antigens in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy
por: Deutscher, Susan L, et al.
Publicado: (2010) -
Nipple Aspirate Fluid at a Glance
por: Patuleia, Susana I. S., et al.
Publicado: (2021)